BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 20534479)

  • 1. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion.
    Grugan KD; Miller CG; Yao Y; Michaylira CZ; Ohashi S; Klein-Szanto AJ; Diehl JA; Herlyn M; Han M; Nakagawa H; Rustgi AK
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11026-31. PubMed ID: 20534479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion.
    Grugan KD; Vega ME; Wong GS; Diehl JA; Bass AJ; Wong KK; Nakagawa H; Rustgi AK
    Cancer Biol Ther; 2013 Sep; 14(9):853-9. PubMed ID: 23792586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.
    Saito S; Morishima K; Ui T; Hoshino H; Matsubara D; Ishikawa S; Aburatani H; Fukayama M; Hosoya Y; Sata N; Lefor AK; Yasuda Y; Niki T
    BMC Cancer; 2015 Feb; 15():82. PubMed ID: 25884729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.
    Okawa T; Michaylira CZ; Kalabis J; Stairs DB; Nakagawa H; Andl CD; Johnstone CN; Klein-Szanto AJ; El-Deiry WS; Cukierman E; Herlyn M; Rustgi AK
    Genes Dev; 2007 Nov; 21(21):2788-803. PubMed ID: 17974918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance.
    Uchida D; Kawamata H; Omotehara F; Nakashiro Ki ; Kimura-Yanagawa T; Hino S; Begum NM; Hoque MO; Yoshida H; Sato M; Fujimori T
    Int J Cancer; 2001 Aug; 93(4):489-96. PubMed ID: 11477552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target.
    Ozawa Y; Nakamura Y; Fujishima F; Felizola SJ; Takeda K; Okamoto H; Ito K; Ishida H; Konno T; Kamei T; Miyata G; Ohuchi N; Sasano H
    BMC Cancer; 2015 Jun; 15():451. PubMed ID: 26036285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas.
    Ren Y; Cao B; Law S; Xie Y; Lee PY; Cheung L; Chen Y; Huang X; Chan HM; Zhao P; Luk J; Vande Woude G; Wong J
    Clin Cancer Res; 2005 Sep; 11(17):6190-7. PubMed ID: 16144920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary human fibroblasts induce diverse tumor invasiveness: involvement of HGF as an important paracrine factor.
    Iwazawa T; Shiozaki H; Doki Y; Inoue M; Tamura S; Matsui S; Monden T; Matsumoto K; Nakamura T; Monden M
    Jpn J Cancer Res; 1996 Nov; 87(11):1134-42. PubMed ID: 9045942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
    Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
    Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
    Kato H; Arao T; Matsumoto K; Fujita Y; Kimura H; Hayashi H; Nishiki K; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Yasuda T; Okuno K; Shiozaki H; Nishio K
    Int J Oncol; 2013 Apr; 42(4):1151-8. PubMed ID: 23426935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.
    Xu FP; Liu YH; Luo XL; Zhang F; Zhou HY; Ge Y; Liu C; Chen J; Luo DL; Yan LX; Mei P; Xu J; Zhuang HG
    Cancer Med; 2016 Dec; 5(12):3500-3511. PubMed ID: 27781415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal squamous cell carcinoma invasion is inhibited by Activin A in ACVRIB-positive cells.
    Loomans HA; Arnold SA; Quast LL; Andl CD
    BMC Cancer; 2016 Nov; 16(1):873. PubMed ID: 27829391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor.
    Oyanagi J; Kojima N; Sato H; Higashi S; Kikuchi K; Sakai K; Matsumoto K; Miyazaki K
    Exp Cell Res; 2014 Aug; 326(2):267-79. PubMed ID: 24780821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
    Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53.
    Liu WT; Jing YY; Yu GF; Chen H; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    Cell Cycle; 2016; 15(7):886-94. PubMed ID: 27077227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
    Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.